AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Sees Significant Growth in Short Interest

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a large increase in short interest in October. As of October 15th, there was short interest totaling 191,030 shares, an increase of 131.3% from the September 30th total of 82,602 shares. Based on an average daily volume of 265,774 shares, the short-interest ratio is presently 0.7 days.

AXIM Biotechnologies Price Performance

Shares of AXIM stock remained flat at $0.00 on Friday. The stock had a trading volume of 34,946 shares, compared to its average volume of 269,237. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc is a biotechnology company focused on developing diagnostic technologies and related healthcare products. Its activities have included research into rapid immunoassay platforms designed to detect biological markers in areas such as infectious disease and oral health.

During the COVID-19 pandemic, AXIM worked on diagnostic products intended to identify SARS-CoV-2 infection and neutralizing antibodies. The company has also explored applications for its testing technologies in oral-care and other clinical settings, although product availability and regulatory status may vary by product and jurisdiction.

AXIM’s business has primarily centered on research, product development, and potential commercialization through regulatory and strategic partnerships.